FrançaisMovemberIn the News
Movember
For more information visit
www.movember.com

In The News

Media Advisory - Prostate Cancer Canada celebrates local Vancouver Hero
Vancouver, British Colombia, April 16 –– Prostate Cancer Canada will honour the late Jack Poole, former VANOC Board Chair and local businessman, with the Local Hero Award. Jack was a generous benefactor to the Vancouver General Hospital and UBC Hospital Foundation with gifts totalling $3 Million for “Jack the Robot”, a da Vinci S HD surgical system, and a $1 Million gift towards the Robert H. N. Ho Research Centre. His lead donation attracted a further $3.5 million in donations including $1.5 million from Jimmy Pattison. Together these donations enabled VGH to become the fourth Canadian hospital to employ robotic technology in surgery.

Media Advisory- Prostate Cancer Canada celebrates local Calgary Hero
Calgary, AB, April 10 –– Local Hero Dr. Jay Lee will be honoured on April 11th at the annual Wake Up Call Breakfast, hosted by Prostate Cancer Canada, in partnership with the Prostate Cancer Centre. Dr. Lee is being recognized for his extraordinary contribution to the fight against prostate cancer.

Click For Information Archive
Print this page.  Bookmark this page. Decrease font size.Increase font size.


In Search of a New Prostate Cancer Biomarker

Dr. Jeremy Squire (2003 and 2005 Research Grants)

Prostatic Intraepithelial Neoplasia (PIN) is a non cancerous prostate condition but it has the potential to turn into cancer. High grade PIN, in particular, is a significant risk factor for prostate cancer. Dr. Squire’s research focuses on the links between high grade PIN and prostate cancer and he has found a promising new biomarker that may help diagnose the cases of PIN that are most likely to turn into prostate cancer. This biomarker is called a telomere. Telomeres are structures found on the ends of chromosomes that protect chromosomes from mutations and play an important role in deciding the number of times a cell can divide.

Every time an older cell divides it loses a tiny piece of DNA from the telomere. This process is called telomere attrition and it can make the telomeres too short to work properly, which causes the chromosomes to rearrange and result in genetic mutations (which in turn lead to high grade PIN and prostate cancer).

Squire’s study looked at a group of 68 men with high grade PIN (but not prostate cancer) and compared the lengths of their telomeres. The study found several significant links between short telomere length and long term diagnosis of prostate cancer – suggesting that telomere attrition in PIN is the basis of genetic mutations that cause prostate cancer.

In collaboration with local nanotechnology experts, Dr. Squire is now looking for quick and cost effective ways to measure telomere length during biopsies.
Twitter feed temporarily unavailable.
Follow Us On Twitter
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca

Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325

Please note we cannot provide medical advice or endorse specific services, products, treatments or medical centres.
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development Inorbital